- Home
- PDX vs KURA Comparison
PDX vs KURA Comparison
Compare PDX & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDX | KURA |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | NY | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 931.2M | 830.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PDX | KURA |
|---|---|---|
| Price | $19.82 | $8.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $26.88 |
| AVG Volume (30 Days) | N/A | ★ 1.4M |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $104,029,000.00 |
| Revenue This Year | N/A | $109.64 |
| Revenue Next Year | N/A | $62.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.52 | $5.41 |
| 52 Week High | $21.05 | $12.49 |
Technical Indicators
Market Signals| Indicator | PDX | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 40.65 |
| Support Level | $19.22 | $8.13 |
| Resistance Level | $20.20 | $9.43 |
| Average True Range (ATR) | 0.38 | 0.49 |
| MACD | 0.12 | -0.07 |
| Stochastic Oscillator | 71.57 | 36.42 |
Price Performance
Historical ComparisonAbout PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.